Active Recombinant Human IL32

• Cat.No.: IL32-419H
• Product Overview: Recombinant Human IL32 (Accession # AAS80146) Cys2-Lys131 was produced in E. coli-derived.

Specification

• Source: E. coli
• Species: Human
• Predicted N Terminal: Cys2
• Form: Lyophilized from a 0.2 µm filtered solution in PBS and DTT.
• Bio-activity: Measured by its ability to induce TNF-alpha secretion by RAW 264.7 mouse monocyte/macrophage cellsunder serum free conditions in the presence of muramyl dipeptide (MDP) and Polymyxin B. Netea, M.G. et al. (2005) Proc. Nat. Acad. Sci. 102:16309.The ED50 for this effect is typically 2 - 12 µg/mL.
• Molecular Mass: Recombinant Human IL32 has a calculated MW of 14.9 kDa. In SDS-PAGE migrates as 18.8 kDa, reducing conditions.
• Purity: >85%, by SDS-PAGE under reducing conditions and visualized by silver stain.
• Storage: Avoid repeated freeze-thaw cycles. No activity loss was observed after storage at: In lyophilized state for 1 year (4ºC); After reconstitution under sterile conditions for 3 months (-70ºC).
• Tag: Non
• Protein length: 2-131 a.a.

Gene Information

• Gene Name: IL32 interleukin 32 [ Homo sapiens ]
• Official Symbol: IL32
• Synonyms: IL32; interleukin 32; interleukin-32; natural killer cell transcript 4; NK4; TAIF; TAIFb; TAIFd; interleukin-32 eta; interleukin-32 small; interleukin-32 theta; natural killer cells protein 4; tumor necrosis factor alpha-inducing factor; TAIFa; TAIFc; IL-32beta; IL-32alpha; IL-32delta; IL-32gamma
• Gene ID: 9235
• mRNA Refseq: NM_001012631
• Protein Refseq: NP_001012649
• MIM: 606001
• UniProt ID: P24001
• Chromosome Location: 16p13.3